Oxidative Stress and Cancer: The Role of Nrf2

Soraya Sajadimajd1, Mozafar Khazaei1

  • 1Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Insights

Oxidative stress impacts cell fate, with excessive reactive oxygen species (ROS) promoting cancer. The NRF2 pathway regulates cellular defense, but its deregulation can lead to cancer progression and treatment resistance.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Oxidative stress, an imbalance in reactive oxygen species (ROS) production and detoxification, critically influences cell fate.
  • Excessive ROS can trigger apoptosis for normal cell death, but also promote carcinogenesis by deregulating biomolecules in cells with faulty signaling.
  • The Nuclear factor erythroid 2-related factor 2 (NRF2) is a master regulator protecting cells against oxidative and electrophilic stress.

Purpose of the Study:

  • To elucidate the role of the NRF2 signaling pathway in cellular response to oxidative stress and its implications in carcinogenesis.
  • To understand the regulatory mechanisms of NRF2 activation and its link to cancer development, including proliferation, metastasis, and chemoresistance.
  • To explore the potential of NRF2 modulation in personalized cancer therapy.

Main Methods:

  • Review of existing literature on oxidative stress, ROS, NRF2, Keap1, and their roles in cellular processes and cancer.
  • Analysis of the molecular mechanisms governing NRF2 activation, including its interaction with Keap1 and the impact of ROS.
  • Examination of the consequences of NRF2/Keap1 deregulation in cancer, such as mutations and oncogene activation.

Main Results:

  • NRF2 controls the expression of genes encoding antioxidant enzymes, detoxifying factors, anti-apoptotic proteins, and drug transporters.
  • Under oxidative stress, ROS triggers the dissociation of the NRF2:Keap1 complex, leading to NRF2 nuclear import and activation of cytoprotective genes.
  • Deregulation of NRF2/Keap1 is linked to constitutive NRF2 activation, promoting cancer cell survival, proliferation, metastasis, and chemoresistance.

Conclusions:

  • The interplay between ROS and NRF2 signaling is crucial in the development and progression of cancer.
  • Aberrant NRF2 activation confers survival advantages to cancer cells, contributing to therapeutic challenges.
  • Targeting the NRF2 pathway holds promise for developing novel, personalized cancer treatment strategies.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
540
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K